Arimidex With or Without Faslodex In Postmenopausal Women With HR Positive Breast Cancer (PACT001)

Share this content:
Arimidex With or Without Faslodex In Postmenopausal Women With HR Positive Breast Cancer (PACT001)
 
Sponsors and Collaborators
Baylor Breast Care Center
AstraZeneca
 
Contact
Ashley Whittington, BS
713-798-1999
sawhitti@bcm.edu
 
Investigator
Mothaffar Rimawi, MD
Baylor College of Medicine
 
ClinicalTrial.gov Identifier

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs